Stockreport

Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Report

Lantern Pharma Inc.  (LTRN) 
PDF DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN) (“Lantern” or the “Company”), an AI-driven, clinical-stage oncology company leveraging its proprietary RA [Read more]